RIGHTSMIL Stock Other OTC
Equities
US76657X1037
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Bud Genius, Inc. cancelled the acquisition of Evergreen Licensing. | CI |
2015 | Bud Genius, Inc.'s Board intends to launch an Equity Buyback. | CI |
Financials (USD)
Sales 2009 | - | Sales 2010 | 0.04 | Capitalization | 11.25K |
---|---|---|---|---|---|
Net income 2009 | - | Net income 2010 | - | EV / Sales 2009 | - |
Net Debt 2009 | 489K | Net Debt 2010 | 396K | EV / Sales 2010 | 9,639,795 x |
P/E ratio 2009 |
-23.5
x | P/E ratio 2010 |
-
| Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 61.59% |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |